June 17, 2019
IVERIC bio, Catalent’s Paragon Gene Therapy in deal for Orphan Inherited Retinal Diseases
NEW YORK & SOMERSET, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (NASDAQ: ISEE) and Catalent Biologics, today announced that they have entered into…